29 April 2011
Dr. Henry Daniell has served on the faculty of Washington State University, University of Idaho Auburn University and the University of Central Florida (as Pegasus Professor & Trustee Chair). He is currently with the UCF Burnett College of Biomedical Sciences. His areas on research interest include DNA replication in chloroplast and mitochondria, identification of new genes in organelle genomes, promiscuous DNA and their evolutionary significance, maternal inheritance, transgene containment, photosynthesis (Rubisco, electron transport), chlorophyll biosynthesis, chloroplast development, in organello protein synthesis, transcription, RNA processing, RNA stability, translation, protein import, proteolysis and regulation of these processes.
He pioneered the chloroplast genetic engineering approach in the 1980s and advanced this concept to confer useful agronomic traits (for herbicide, insect, disease resistance, drought & salt tolerance, photoremediation, cytoplasmic male sterility, etc.) and to express biomaterials (e.g. biopolymers) in transgenic plants. He has extended this technology to major crops, including cotton. Most important are his contributions to human medicine, for which he has engineered transgenic plants that produce pharmaceuticals to treat diabetes and hepatitis, as well as vaccines for anthrax, plague, cholera, and other bioterrorism agents. He is currently developing an additional arm to his technology that will enable therapeutic proteins to be administered orally, being able to deliver an effective inoculation to widespread communities.
Dr. Daniell has published over 150 research articles which are cited in the scientific literature over 1500 times. His research has been featured in the national and international press (e.g. New York Times and Scientific American), highlighted by top scientific journals (e.g. Science and Nature), and featured by several major television networks (NBC, ABC, CBS, and CNN).